CVE(CVE)
CVE
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $56.06B | $52.14B | $55.67B | $49.07B | $49.30B |
| Low | $50.23B | $44.81B | $48.06B | $42.37B | $42.57B |
| High | $61.26B | $60.67B | $62.00B | $54.65B | $54.90B |
| EBITDA Avg | $10.07B | $9.36B | $9.99B | $8.81B | $8.85B |
| Low | $9.02B | $8.04B | $8.63B | $7.61B | $7.64B |
| High | $11.00B | $10.89B | $11.13B | $9.81B | $9.86B |
| EBIT Avg | $5.23B | $4.87B | $5.19B | $4.58B | $4.60B |
| Low | $4.69B | $4.18B | $4.48B | $3.95B | $3.97B |
| High | $5.72B | $5.66B | $5.78B | $5.10B | $5.12B |
| Net Income Avg | $8.07B | $6.32B | $8.24B | $8.11B | $8.69B |
| Low | $7.06B | $5.30B | $3.50B | $6.67B | $7.14B |
| High | $9.07B | $7.35B | $8.76B | $9.31B | $9.97B |
| EPS Avg | $4.45 | $3.55 | $3.91 | $4.46 | $4.77 |
| Low | $3.88 | $2.91 | $1.92 | $3.67 | $3.93 |
| High | $4.99 | $4.04 | $4.81 | $5.12 | $5.48 |
| Analysts (Rev / EPS) | 3 / 6 | 3 / 6 | 1 / 7 | 1 / 2 | 1 / 5 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $14.99B | $14.39B | $12.77B | $12.92B | $13.04B | $13.06B | $12.81B | $12.85B |
| Low | $13.91B | $14.04B | $12.46B | $12.60B | $12.72B | $12.74B | $12.50B | $12.54B |
| High | $16.06B | $14.73B | $13.07B | $13.23B | $13.35B | $13.37B | $13.11B | $13.16B |
| EBITDA Avg | $2.69B | $2.58B | $2.29B | $2.32B | $2.34B | $2.34B | $2.30B | $2.31B |
| Low | $2.50B | $2.52B | $2.24B | $2.26B | $2.28B | $2.29B | $2.24B | $2.25B |
| High | $2.88B | $2.64B | $2.35B | $2.37B | $2.40B | $2.40B | $2.35B | $2.36B |
| EBIT Avg | $1.40B | $1.34B | $1.19B | $1.21B | $1.22B | $1.22B | $1.19B | $1.20B |
| Low | $1.30B | $1.31B | $1.16B | $1.18B | $1.19B | $1.19B | $1.17B | $1.17B |
| High | $1.50B | $1.37B | $1.22B | $1.23B | $1.25B | $1.25B | $1.22B | $1.23B |
| Net Income Avg | $2.23B | $1.81B | $1.64B | $1.54B | $1.68B | $1.53B | $1.57B | $1.58B |
| Low | $2.16B | $1.75B | $1.59B | $1.49B | $1.62B | $1.49B | $1.52B | $1.53B |
| High | $2.30B | $1.86B | $1.69B | $1.58B | $1.73B | $1.58B | $1.62B | $1.63B |
| EPS Avg | $1.19 | $0.96 | $0.87 | $0.82 | $0.89 | $0.82 | $0.84 | $0.84 |
| Low | $1.15 | $0.93 | $0.84 | $0.79 | $0.86 | $0.79 | $0.81 | $0.82 |
| High | $1.22 | $0.99 | $0.90 | $0.84 | $0.92 | $0.84 | $0.86 | $0.87 |
| Analysts (Rev / EPS) | 1 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |